Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmaceutics|November 16, 2019
Polymeric Nanoparticles Based on Tyrosine-Modified, Low Molecular Weight Polyethylenimines for siRNA DeliveryAlexander Ewe, Sandra Noske, Michael Karimov, et al.
Nanomaterials (Basel, Switzerland)|September 15, 2020
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene KnockdownSandra Noske, Michael Karimov, Achim Aigner, et al.
Pharmaceutics|March 27, 2025
Analysis of Polymer/siRNA Nanoparticle Efficacy and Biocompatibility in 3D Air-Liquid Interface Culture Compared to 2D Cell CultureSandra Noske, Martin Krueger, Alexander Ewe, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 19, 2024
Spray-drying of PEI-/PPI-based nanoparticles for DNA or siRNA deliverySandra Noske, Michael Karimov, Martin Krüger, et al.
International Journal of Pharmaceutics|December 13, 2021
Non-viral siRNA transfection of primary mesenchymal stromal cells (MSCs): Assessment of tyrosine-modified PEI and PPI efficacy and biocompatibilitySandra Noske, Michael Karimov, Max Hansen, et al.
International Journal of Pharmaceutics|January 15, 2022
Unmodified and tyrosine-modified polyethylenimines as potential carriers for siRNA: Biophysical characterization and toxicityMałgorzata Kubczak, Sylwia Michlewska, Michael Karimov, et al.
Neoplasia (New York, N.Y.)|January 26, 2025
Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostatTamara Zenz, Robert Jenke, Denys Oliinyk, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|May 1, 2021
Tyrosine-modified linear PEIs for highly efficacious and biocompatible siRNA delivery in vitro and in vivoMichael Karimov, Marion Schulz, Tim Kahl, et al.
Pageof 1